Purchase Order HHSN272201601278P
Award Date
9/7/16
Potential Completion Date
9/18/17
Potential Value
$28K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Medigen, Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21701, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Medigen, Inc., a biotechnology company specializing in vaccine development. The $815,000.00 contract is for laboratory and testing services. Medigen has previously received grants from NIAID totaling over $4 million to support R&D on novel live-attenuated vaccines. This contract does not have a...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. The contract, valued at $89,871, was awarded to Medigen, Inc., a biotechnology company that specializes in vaccine development and manufacturing. The contract has a firm fixed price pricing type and an ultimate completion date of May 30, 2010. Medigen has received numerous federal grants...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Fraunhofer USA, Inc. for the development of influenza virus-like particles in a plant-based system. The contract has a ceiling value of $364,793 and a period of performance that ends on March 29, 2017. The contract was not set aside for a specific business type. Fraunhofer USA, Inc. is the...
This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...
<p>This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Medix Biochemica USA, Inc. for $17,394.00. The contract is for the delivery of human biologicals with a period of performance through January 16, 2025. There is no set-aside designation for this contract. Medix Biochemica USA, Inc. is a for-profit manufacturer of goods, and this appears to be one of their recent federal contract awards.</p>
This is a $37,000 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Protein Sciences Corp, a for-profit manufacturer, to provide purified recombinant proteins. The contract has no set-aside designation. Protein Sciences Corp has received multiple federal contract awards from HHS's Office of the Assistant Secretary for Preparedness and Response...
This federal contract award, with the ID HHSN272201000923P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. Department of Health and Human Services. The contract, with a firm fixed price of $21,616.50, was awarded to Immune Technology Corp., a minority-owned, Asian-Pacific American-owned, for-profit manufacturer of goods. The contract is for the production of 200 mg plasmid DNA, designated as VRC 5566, for NIAID's Vaccine Research Center (VRC). The...
This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), is for the NIAID Vaccine Research Center (VRC) to establish mRNA vaccine production capabilities. The $30,320,960.00 cost-plus-fixed-fee delivery order contract was awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract has an ultimate completion date of April 18, 2029 and was not set aside for any...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
<p>This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to MedImmune Biologics, Inc. for the provision of influenza virus vaccines. The contract has a total ceiling value of $95,527.50 and an ultimate completion date of December 21, 2015. The contract was not set aside for any specific business type. MedImmune Biologics, Inc. is the prime contractor for this award, which is part of the Medical Supply Chain program within the Department of Defense.</p>